The largest study to investigate the role of inflammatory biomarkers in hospitalized COVID-19 patients uncovers risk factors for worse health outcomes in those with diabetes.
Researchers say new measures of kidney function are needed for people with the condition, which is caused by damage to, or malformation of, the developing brain.
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
A specific type of blood thinner may be a safer choice for reducing stroke risk in those who have both end-stage kidney disease and atrial fibrillation.
New research shows how expression of certain genes might offer doctors a warning sign when a kidney transplant is poised to fail.